|
1
|
Kaatsch P: Epidemiology of childhood
cancer. Cancer Treat Rev. 36:277–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JA, Kim MS, Kim DH, Lim JS, Yoo JY,
Koh JS, Lee SY, Jeon DG and Park KD: Relative tumor burden
predticts metastasis-free survival in pediatric osteosarcoma.
Pediatr Blood Cancer. 50:195–200. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bacci G, Longhi A, Versari M, Mercuri M,
Briccoli A and Picci A: Prognostic factors for osteosarcoma of the
extremity treated with neoadjuvant chemotherapy: 15-year experience
in 789 patients treated at a single institution. Cancer.
106:1154–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O'Driscoll L: Mechanisms of drug
sensitivity and resistance in cancer. Curr Cancer Drug Targets.
9:250–251. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anninga JK, Gelderblom H, Fiocco M, Kroep
JR, Taminiau AH, Hogendoorn PC and Egeler AM: Chemotherapeutic
adjuvant treatment for osteosarcoma: Where do we stand? Eur J
Cancer. 47:2431–2445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment - where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McTiernan A, Jinks RC, Sydes MR, Uscinska
B, Hook JM, van Glabbeke M, Bramwell V, Lewis IJ, Taminiau AH,
Nooij MA, et al: Presence of chemotherapy-induced toxicity predicts
improved survival in patients with localised extremity osteosarcoma
treated with doxorubicin and cisplatin: A report from the European
osteosarcoma intergroup. Eur J Cancer. 48:703–712. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Janeway KA and Grier HE: Sequelae of
osteosarcoma medical therapy: A review of rare acute toxicities and
late effects. Lancet Oncol. 11:670–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Acheson RM: Acridines. Interscience
Publishers; New York, NY: pp. 10–90. 1973
|
|
12
|
Li HJ and Crothers DM: Relaxation studies
of the proflavine-DNA complex: The kinetics of an intercalation
reaction. J Mol Biol. 39:461–477. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Faller LD and LaFond RE: Binding
properties of oligomeric alpha-chymotrypsin. Biochemistry.
10:1033–1041. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bubel HC and Wolff DA: Proflavine
inhibition of vaccinia virus synthesis. J Bacteriol. 89:977–983.
1965.PubMed/NCBI
|
|
15
|
Scholtissek C and Rott R: Binding of
proflavine to deoxyribonucleic acid and ribonucleic acid and its
biological significance. Nature. 204:39–43. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Orgel A and Brenner S: Mutagenesis of
bacteriophage T4 by acridines. J Mol Biol. 3:762–768. 1961.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lerman LS: Structural consideration in the
interaction of DNA and acridines. J Mol Biol. 3:18–30. 1961.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Simard R: Specific nuclear and nucleolar
ultrastructural lesions induced by proflavin and similarly acting
antimetabolites in tissue culture. Cancer Res. 26:2316–2328.
1966.PubMed/NCBI
|
|
19
|
Furuya N, Liang XH and Levin B: Autophagy
and cancerAutophagy. Klionsky DJ: Landes Bioscience; Georgetown,
TX: pp. 244–253. 2004
|
|
20
|
Mathew R, Karp CM, Beaudoin B, Vuong N,
Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al:
Autophagy suppresses tumorigenesis through elimination of p62.
Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hassan S, Laryea D, Mahteme H, Felth J,
Fryknäs M, Fayad W, Linder S, Rickardson L, Gullbo J, Graf W, et
al: Novel activity of acriflavine against colorectal cancer tumor
cells. Cancer Sci. 102:2206–2213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Strese S, Fryknäs M, Larsson R and Gullbo
J: Effects of hypoxia on human cancer cell line chemosensitivity.
BMC Cancer. 13:3312013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wong CC, Zhang H, Gilkes DM, Chen J, Wei
H, Chaturvedi P, Hubbi ME and Semenza GL: Inhibitors of
hypoxia-inducible factor 1 block breast cancer metastatic niche
formation and lung metastasis. J Mol Med (Berl). 90:803–815. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lim MJ, Ahn JY, Han Y, Yu CH, Kim MH, Lee
SL, Lim DS and Song JY: Acriflavine enhances radiosensitivity of
colon cancer cells through endoplasmic reticulum stress-mediated
apoptosis. Int J Biochem Cell Biol. 44:1214–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Polglase AL, McLaren WJ, Skinner SA,
Kiesslich R, Neurath MF and Delaney PM: A fluorescence confocal
endomicroscope for in vivo microscopy of the upper- and the
lower-GI tract. Gastrointest Endosc. 62:686–695. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kiesslich R, Goetz M, Vieth M, Galle PR
and Neurath MF: Confocal laser endomicroscopy. Gastrointest Endosc
Clin N Am. 15:715–731. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Keyhani E, Khavari-Nejad S, Keyhani J and
Attar F: Acriflavine-mediated apoptosis and necrosis in yeast
Candida utilis. Ann NY Acad Sci. 1171:284–291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Simard R, Langelier, Mandeville NM and
Royal A: Inhibitors as tools in elucidating the structure and
function of the nucleusThe Cell Nucleus. Busch H: 3. Academic Press
Inc.; London: pp. 447–487. 1974
|
|
29
|
Mizushima N and Yoshimori T: How to
interpret LC3 immunoblotting. Autophagy. 3:542–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
